CARD9 and neoplasm: Both studies showed that Card9-deficient mice were not only more susceptible to chemically induced colitis as described above, but also developed a higher tumor burden upon challenge with the carcinogenic agent axozymethane (AOM) followed by DSS (AOM–DSS).